|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||199.57 - 201.22|
|52-week range||166.56 - 240.96|
|Beta (5Y monthly)||1.37|
|PE ratio (TTM)||0.36|
|Earnings date||24 Oct 2023 - 30 Oct 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Key Insights IQVIA Holdings' estimated fair value is US$299 based on 2 Stage Free Cash Flow to Equity Current share...
RESEARCH TRIANGLE PARK, N.C., September 26, 2023--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has appointed Richard Staub III, currently senior advisor to the Chairman and CEO, as president of its Research & Development Solutions (R&DS) business unit.
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...